Luxi Chemical Group Past Earnings Performance
Past criteria checks 4/6
Luxi Chemical Group's earnings have been declining at an average annual rate of -0.01%, while the Chemicals industry saw earnings growing at 6.3% annually. Revenues have been growing at an average rate of 10% per year. Luxi Chemical Group's return on equity is 10%, and it has net margins of 6.4%.
Key information
-0.01%
Earnings growth rate
-5.2%
EPS growth rate
Chemicals Industry Growth | 12.1% |
Revenue growth rate | 10.0% |
Return on equity | 10.0% |
Net Margin | 6.4% |
Next Earnings Update | 31 Oct 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Luxi Chemical Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 27,855 | 1,796 | 629 | 1,082 |
31 Mar 24 | 25,530 | 1,064 | 624 | 980 |
31 Dec 23 | 25,358 | 819 | 634 | 933 |
30 Sep 23 | 24,781 | 546 | 670 | 820 |
30 Jun 23 | 25,257 | 614 | 649 | 825 |
31 Mar 23 | 29,286 | 2,157 | 663 | 989 |
01 Jan 23 | 30,357 | 3,155 | 637 | 990 |
30 Sep 22 | 31,841 | 4,129 | 688 | 861 |
30 Jun 22 | 33,966 | 4,722 | 654 | 958 |
31 Mar 22 | 33,229 | 4,940 | 607 | 998 |
01 Jan 22 | 31,794 | 4,619 | 601 | 1,041 |
30 Sep 21 | 28,986 | 3,960 | 519 | 1,149 |
30 Jun 21 | 24,632 | 3,231 | 520 | 952 |
31 Mar 21 | 20,455 | 1,807 | 495 | 691 |
31 Dec 20 | 17,592 | 825 | 461 | 580 |
30 Sep 20 | 16,541 | 1,316 | 574 | 508 |
30 Jun 20 | 15,711 | 1,179 | 687 | 499 |
31 Mar 20 | 16,592 | 1,381 | 821 | 553 |
31 Dec 19 | 18,207 | 1,726 | 960 | 586 |
30 Sep 19 | 19,258 | 1,597 | 976 | 926 |
30 Jun 19 | 20,607 | 2,121 | 926 | 891 |
31 Mar 19 | 21,362 | 2,612 | 914 | 755 |
31 Dec 18 | 21,286 | 3,068 | 897 | 630 |
30 Sep 18 | 20,469 | 3,094 | 904 | 238 |
30 Jun 18 | 19,082 | 2,984 | 887 | 265 |
31 Mar 18 | 16,947 | 2,392 | 906 | 219 |
31 Dec 17 | 15,762 | 1,815 | 908 | 187 |
30 Sep 17 | 14,310 | 1,145 | 896 | 137 |
30 Jun 17 | 13,122 | 676 | 1,028 | 0 |
31 Mar 17 | 12,300 | 477 | 961 | 0 |
31 Dec 16 | 10,949 | 253 | 918 | 0 |
30 Sep 16 | 10,500 | 118 | 826 | 0 |
30 Jun 16 | 11,082 | 139 | 824 | 0 |
31 Mar 16 | 11,801 | 202 | 854 | 0 |
31 Dec 15 | 12,871 | 289 | 943 | 0 |
30 Sep 15 | 13,810 | 409 | 1,015 | 0 |
30 Jun 15 | 13,930 | 463 | 960 | 0 |
31 Mar 15 | 13,512 | 381 | 948 | 0 |
31 Dec 14 | 13,029 | 361 | 886 | 0 |
30 Sep 14 | 12,323 | 337 | 781 | 0 |
30 Jun 14 | 11,467 | 246 | 687 | 0 |
31 Mar 14 | 11,397 | 252 | 645 | 0 |
31 Dec 13 | 11,056 | 306 | 625 | 0 |
Quality Earnings: 000830 has high quality earnings.
Growing Profit Margin: 000830's current net profit margins (6.4%) are higher than last year (2.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 000830's earnings have declined by 0.01% per year over the past 5 years.
Accelerating Growth: 000830's earnings growth over the past year (192.6%) exceeds its 5-year average (-0.01% per year).
Earnings vs Industry: 000830 earnings growth over the past year (192.6%) exceeded the Chemicals industry -4.7%.
Return on Equity
High ROE: 000830's Return on Equity (10%) is considered low.